A tough retirement nest egg, the whistle-blowing way
By
James M. Berklan
Nov 07, 2013
Two big reactions hit me when news of Johnson & Johnson’s $2.2 billion Risperdal settlement with the government landed this week. First, J&J probably made a lot more than it’s paying out and,...
The calm before the antipsychotics storm
By
James M. Berklan
May 30, 2012
If you’re a Daily McKnight’s reader, it’s a good thing. Otherwise, you might have never known that a federal measure calling for closer monitoring of antipsychotic drug use in nursing...
Antipsychotics report will have severe side effects
By
John O'Connor
Jul 13, 2012
Antipsychotic drugs are often used to calm residents with dementia. This reality is common knowledge among most people who have spent more than a few minutes in a nursing facility. But it is apparently...